PACIFIC BIOSCIENCES OF CALIF (PACB)
US69404D1081 - Common Stock
Tuesday's session: top gainers and losers
Wondering how the US markets performed one hour before the close of the markets on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.
The Cathie Wood Stock Shuffle: 4 Names She’s Loving, 3 She’s Leaving
Investing with the Ark Invest guru is a roller coaster ride, but she always keeps her big ideas for the future in front of her.
Tuesday's session is buzzing with activity. Check out the stocks that are attracting the most attention and driving market activity!
Which stocks are most active on Tuesday?
Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes.
Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements.
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Tuesday.
Let's have a look at the gap up and gap down stocks in today's session.
Which stocks are moving before the opening bell on Tuesday?
Discover the top movers in Tuesday's pre-market session and stay informed about market dynamics.
PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance
/PRNewswire/ – PacBio (NASDAQ: PACB) today announced preliminary, unaudited revenue for the quarter ended March 31, 2024. Preliminary First Quarter Results...
PacBio Grants Equity Incentive Award to New Employee
/PRNewswire/ -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation...
Pacific Biosciences of California Becomes Oversold (PACB)
PACB Trading Below Director's Recent Buy Price
PacBio Announces PureTarget™ Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research Solutions
/PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the PureTarget repeat...
PacBio to Present at Upcoming Investor Conferences
/PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be...
Pacific Biosciences of California is Now Oversold (PACB)
First Week of PACB April 19th Options Trading
Pacific Biosciences of California Non-GAAP EPS of -$0.27 beats by $0.01, revenue of $58.36M in-line (NASDAQ:PACB)
Pacific Biosciences of California (PACB) reports Q4 non-GAAP EPS of -$0.27, beating estimates by $0.01, with revenue of $58.36M (+113.4% YoY) meeting...
PacBio Announces Fourth Quarter and Fiscal Year 2023 Financial Results
/PRNewswire/ -- PacBio (NASDAQ: PACB) today announced financial results for the quarter and fiscal year ended December 31, 2023. Fourth quarter results Revenue...
7 Stocks Cathie Wood Is Still Loading Up On in Q1
You won't find many timid bets among the Cathie Wood stocks she believes will dramatically alter our future.
Experiential Marketing Firm VOLO Events Agency Wins Best Event Technology Award for PacBio Product Launch
/PRNewswire/ -- VOLO Events Agency (VOLO), a leading producer of experiential marketing and live events for global brands, has won the best Event Technology...
PacBio Announces HiFi Prep Kit 96 and HiFi Plex Prep Kit 96 for Long-Read Sequencing Applications at Scale
/PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced two new high throughput...
PacBio to Report Fourth Quarter 2023 Financial Results on February 15, 2024
/PRNewswire/ -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its fourth quarter 2023 financial results on...
Cantor picks RCEL as best 2024 medtech idea; bullish on PACB, AXGN, CERS
Cantor Fitzgerald picks AVITA Medical (RCEL) as its best 2024 medtech idea, while remaining bullish on AXGN, CERS, ELUT, XGN, NNOX, NPCE, NYXH, SIBN, and PACB. Read more here.